BICALUTAMIDA ACTAVIS 50mg film-coated tablets
bicalutamide Indicated for: prostate cancer
letter B · page 14
bicalutamide Indicated for: prostate cancer
bicalutamide Indicated for: prostate cancer
bicalutamide Indicated for: prostate cancer
bicalutamide Indicated for: prostate cancer
bicalutamide Indicated for: prostate cancer
bicalutamide Indicated for: prostate cancer
bicalutamide Indicated for: prostate cancer
bicalutamide Indicated for: prostate cancer
bicalutamide Indicated for: prostate cancer
bicalutamide Indicated for: prostate cancer
bicalutamide Indicated for: prostate cancer
bicalutamide Indicated for: prostate cancer
bicalutamide Indicated for: prostate cancer
bicalutamide Indicated for: prostate cancer
bicalutamide Indicated for: prostate cancer
sodium hydrogen carbonate Indicated for: urinary alkalinization; metabolic acidosis
B05XA02 Blood and blood forming organs | I.v. solution additives | Electrolyte solutions
sodium hydrogen carbonate Indicated for: urinary alkalinization; metabolic acidosis
B05XA02 Blood and blood forming organs | I.v. solution additives | Electrolyte solutions
sodium hydrogen carbonate Indicated for: urinary alkalinization; metabolic acidosis
B05XA02 Blood and blood forming organs | I.v. solution additives | Electrolyte solutions
bicalutamide Indicated for: prostate cancer
carmustine Indicated for: cancer
L01AD01 Antineoplastic and immunomodulating agents | Alkylating agents | Nitrosoureas